Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Mitohormesis (MM) Treatment in Stroke Rehabilitation.

NCT07850518 is registered in ClinicalTrials.gov with QuantumTX Pte Ltd as lead sponsor.

NCT NCT07850518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07850518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Mitohormesis (MM) Treatment in Stroke Rehabilitation.
Lead sponsor
QuantumTX Pte Ltd
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2024
Completion date
April 1, 2026
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

physical functional performance, rehabilitation program, stroke rehabilitation